Ohio State University, Hilliard
DSI Research, LLC d/b/a ObjectiveHealth Clinical Research - Springboro, Springboro
Gastro Intestinal Research Institute of Northern Ohio, LLC, Westlake

ReclutandoFase 2

Edades de 18 a 80 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07415044

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

Dayton Gastroenterology, LLC, Dayton

ReclutandoFase 2

Edades de 18 a 80 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07186101

A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

University Hospitals Cleveland Medical Center /ID# 271831, Cleveland

ReclutandoFase 3

Edades de 2 a 17 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07071519

Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)

Cleveland Clinic Foundation, Cleveland

ReclutandoFase 2

Edades de 18 a 75 · Todos los sexos · Actualizado el 21 sept 2026 · NCT07513181

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

University of Cincinnati, Cincinnati
Ohio Gastroenterology group, Inc., Columbus
Gastro Intestinal Research Institute of Northern Ohio, LLC., Westlake

ReclutandoFase 4

Edades de 18 a 65 · Todos los sexos · Actualizado el 21 sept 2026 · NCT06095128

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Ohio Gastroenterology Group Inc. - Site Number: 8400006, Columbus
OSU Wexner Medical Center - Site Number: 8400077, Columbus
North Shore Gastroenterology Research - Site Number: 8400130, Westlake

ReclutandoFase 3

Edades de 16 a 80 · Todos los sexos · Actualizado el 15 sept 2026 · NCT07185009

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Gastro Health Research - Cincinnati, Cincinnati
DSI Research Northridge LLC, Dayton
Gastro Health Research - Liberty Township, Liberty Township
y 3 más

ReclutandoFase 4

Edades de 18 a 80 · Todos los sexos · Actualizado el 15 sept 2026 · NCT06581328

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

Great Lakes Gastroenterology Research, LLC, Mentor

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 ago 2026 · NCT07577856

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Gastroenterology & Hepatology Specialists, Inc. - Site Number: 8400139, Canton
Ohio Gastroenterology Group Inc. - Site Number: 8400006, Columbus
OSU Wexner Medical Center - Site Number: 8400077, Columbus
y 4 más

ReclutandoFase 3

Edades de 16 a 80 · Todos los sexos · Actualizado el 20 ago 2026 · NCT07184996

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

University of Cincinnati, Cincinnati

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 ago 2026 · NCT07237516

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

GCGA Physicians, LLC dba / Gastro Health Research, Cincinnati
NexGen Research, Lima

ReclutandoFase 2

Edades de 18 a 75 · Todos los sexos · Actualizado el 30 jul 2026 · NCT06598943

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

University of Cincinnati College of Medicine, Cincinnati
Gastro Intestinal Research Institute of Northern Ohio, LLC, Westlake

ReclutandoEstudio observacional

Edades de 18 a 64 · Todos los sexos · Actualizado el 9 jul 2026 · NCT06398626

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

University Hospitals Cleveland Medical Center Rainbow Babies & Children's Hospital, Cleveland
University Hospitals Cleveland Medical Center, Cleveland

ReclutandoFase 2

Edades de 12 a 17 · Todos los sexos · Actualizado el 8 jul 2026 · NCT05287126

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

University Children's Clinic, Cleveland
Cleveland Clinic, Cleveland

ReclutandoFase 3

Edades de 2 a 17 · Todos los sexos · Actualizado el 22 jun 2026 · NCT06405087

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

University Hospitals Cleveland Medical Center - 11100 Euclid Ave, Cleveland

ReclutandoFase 3

Edades de 2 en adelante · Todos los sexos · Actualizado el 7 may 2026 · NCT05442567

ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool

Gastro Intestinal Research Institute of Northern Ohio,, Westlake

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 22 en adelante · Todos los sexos · Actualizado el 28 abr 2026 · NCT06810518

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Mirador Therapeutics Selected Site, Cincinnati
Mirador Therapeutics Selected Site, Liberty Township

ReclutandoFase 2

Edades de 18 a 80 · Todos los sexos · Actualizado el 12 mar 2026 · NCT07113522

Evaluation of the SMART IBD App in Pediatric IBD

Cincinnati Children's Hospital Medical Center, Cincinnati

Reclutando

Edades de 13 a 17 · Todos los sexos · Actualizado el 21 nov 2025 · NCT07195123

Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

University of Cincinnati, Cincinnati

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 8 may 2025 · NCT06750731

De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.